| pubmed-article:2236464 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2236464 | lifeskim:mentions | umls-concept:C0205653 | lld:lifeskim |
| pubmed-article:2236464 | lifeskim:mentions | umls-concept:C0020934 | lld:lifeskim |
| pubmed-article:2236464 | lifeskim:mentions | umls-concept:C1269683 | lld:lifeskim |
| pubmed-article:2236464 | lifeskim:mentions | umls-concept:C1522577 | lld:lifeskim |
| pubmed-article:2236464 | lifeskim:mentions | umls-concept:C0332154 | lld:lifeskim |
| pubmed-article:2236464 | lifeskim:mentions | umls-concept:C0205265 | lld:lifeskim |
| pubmed-article:2236464 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:2236464 | pubmed:dateCreated | 1990-12-14 | lld:pubmed |
| pubmed-article:2236464 | pubmed:abstractText | This preliminary followup of adolescents (n = 16) with prepubertal-onset major depressive disorder (MDD) suggests that a significant number continue to be depressed or possibly depressed (62%) and have moderate to severe ongoing psychosocial adjustment problems. A concomitant diagnosis of conduct or oppositional disorder at index assessment was a risk factor for an increased incidence of interim depressive episodes and more severe psychosocial adjustment problems including alcohol and drug abuse. | lld:pubmed |
| pubmed-article:2236464 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2236464 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2236464 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2236464 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2236464 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2236464 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2236464 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2236464 | pubmed:issn | 0048-5764 | lld:pubmed |
| pubmed-article:2236464 | pubmed:author | pubmed-author:PreskornS HSH | lld:pubmed |
| pubmed-article:2236464 | pubmed:author | pubmed-author:WronaMM | lld:pubmed |
| pubmed-article:2236464 | pubmed:author | pubmed-author:TuckerSS | lld:pubmed |
| pubmed-article:2236464 | pubmed:author | pubmed-author:HughesC WCW | lld:pubmed |
| pubmed-article:2236464 | pubmed:author | pubmed-author:HassaneinRR | lld:pubmed |
| pubmed-article:2236464 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2236464 | pubmed:volume | 26 | lld:pubmed |
| pubmed-article:2236464 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2236464 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2236464 | pubmed:pagination | 244-8 | lld:pubmed |
| pubmed-article:2236464 | pubmed:dateRevised | 2009-11-11 | lld:pubmed |
| pubmed-article:2236464 | pubmed:meshHeading | pubmed-meshheading:2236464-... | lld:pubmed |
| pubmed-article:2236464 | pubmed:meshHeading | pubmed-meshheading:2236464-... | lld:pubmed |
| pubmed-article:2236464 | pubmed:meshHeading | pubmed-meshheading:2236464-... | lld:pubmed |
| pubmed-article:2236464 | pubmed:meshHeading | pubmed-meshheading:2236464-... | lld:pubmed |
| pubmed-article:2236464 | pubmed:meshHeading | pubmed-meshheading:2236464-... | lld:pubmed |
| pubmed-article:2236464 | pubmed:meshHeading | pubmed-meshheading:2236464-... | lld:pubmed |
| pubmed-article:2236464 | pubmed:meshHeading | pubmed-meshheading:2236464-... | lld:pubmed |
| pubmed-article:2236464 | pubmed:meshHeading | pubmed-meshheading:2236464-... | lld:pubmed |
| pubmed-article:2236464 | pubmed:year | 1990 | lld:pubmed |
| pubmed-article:2236464 | pubmed:articleTitle | Followup of adolescents initially treated for prepubertal-onset major depressive disorder with imipramine. | lld:pubmed |
| pubmed-article:2236464 | pubmed:affiliation | Psychiatric Research Institute, St. Francis Regional Medical Center, Wichita, KS. | lld:pubmed |
| pubmed-article:2236464 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2236464 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
